Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
67.03
+2.02 (3.11%)
Apr 13, 2026, 10:39 AM EDT - Market open

Cytokinetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,2567,8125,5618,4864,3453,865
Market Cap Growth
59.80%40.49%-34.47%95.29%12.42%161.92%
Enterprise Value
8,8128,1545,2438,5994,2993,649
Last Close Price
67.0363.5447.0483.4945.8245.58
PE Ratio
--9.72-8.94-15.32-10.58-16.28
PS Ratio
93.7788.73300.991126.9345.9454.88
PB Ratio
--11.84-41.08-21.97-40.2715.85
P/TBV Ratio
-12.20-11.57-38.91-20.86-38.1514.37
P/FCF Ratio
--14.61-13.91-20.41-13.98-20.19
P/OCF Ratio
--15.32-14.05-20.48-14.51-27.12
EV/Sales Ratio
100.0992.61283.791141.9345.4551.81
EV/EBITDA Ratio
--13.54-9.95-17.75-13.50-19.83
EV/EBIT Ratio
--13.32-9.78-17.33-13.26-19.58
EV/FCF Ratio
--15.25-13.11-20.68-13.83-19.06
Debt / Equity Ratio
-1.86-1.86-5.60-1.88-6.831.05
Debt / EBITDA Ratio
-2.13-2.13-1.50-1.56-2.36-1.47
Debt / FCF Ratio
-2.40-2.40-1.97-1.82-2.41-1.41
Net Debt / Equity Ratio
-0.61-0.612.12-0.360.30-0.83
Net Debt / EBITDA Ratio
-0.67-0.670.55-0.290.101.10
Net Debt / FCF Ratio
-0.75-0.750.72-0.340.101.05
Asset Turnover
0.060.060.020.010.100.10
Quick Ratio
4.454.456.086.009.257.28
Current Ratio
4.534.536.176.129.407.45
Return on Equity (ROE)
197.47%197.47%226.00%212.96%-572.15%-120.54%
Return on Assets (ROA)
-43.33%-43.33%-48.18%-53.96%-34.93%-27.10%
Return on Invested Capital (ROIC)
-178.33%-178.33%-271.30%-322.38%-136.01%-104.49%
Return on Capital Employed (ROCE)
-50.10%-50.10%-55.18%-60.08%-38.15%-29.29%
Earnings Yield
-9.51%-10.29%-11.18%-6.53%-9.45%-6.14%
FCF Yield
-6.48%-6.85%-7.19%-4.90%-7.15%-4.95%
Buyback Yield / Dilution
-7.26%-7.25%-16.01%-7.46%-16.83%-19.16%
Total Shareholder Return
-7.26%-7.25%-16.01%-7.46%-16.83%-19.16%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q